Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Centene Corporation Reports 2010 Second Quarter Earnings


      News provided by

      Centene Corporation

      Jul 27, 2010, 06:00 ET

      Share this article

      Share this article


      ST. LOUIS, July 27 /PRNewswire-FirstCall/ -- Centene Corporation (NYSE: CNC) today announced net earnings from continuing operations for the quarter ended June 30, 2010, of $23.0 million, or $0.45 per diluted share.  The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.

      Second Quarter Highlights

      • Quarter-end managed care at-risk membership of 1,531,800, an increase of 242,800 members, or 18.8% year over year.
      • Premium and Service Revenues of $1.051 billion, representing 12.8% year over year growth.
      • Health Benefits Ratio (HBR) of 83.8%, compared to 83.1% in the prior year.  
      • General and Administrative (G&A) expense ratio of 12.7%, compared to 13.9% in the prior year.
      • Earnings from operations of $41.7 million, compared to $31.4 million in the prior year.
      • Earnings from continuing operations, net of income tax expense, increased 11.0% year over year to $23.0 million.  Within the quarter, we incurred a $0.03 charge per diluted share to write off a deferred tax asset associated with our Georgia health plan and benefited by $0.03 per diluted share from a shift in start up costs for Mississippi from the second to the third quarter.  
      • Diluted earnings per share from continuing operations of $0.45.  
      • Days in claims payable of 48.2, including pharmacy claims payable.
      • Estimated 2010 composite premium rate increase between 1% and 3%.

      Other Events

      • In May 2010, our Texas health plan was awarded a new ABD contract in the Dallas service area subject to execution of a final contract.  The new contract is expected to commence during the first quarter of 2011.  
      • In June 2010, we completed the acquisition of certain assets of Carolina Crescent Health Plan.  We now serve 92,600 at-risk members in South Carolina as of June 30, 2010.  
      • In June 2010, our Indiana health plan was selected to negotiate a statewide managed care contract effective January 1, 2011.  Upon successful execution of the contract, we will continue to serve Hoosier Healthwise members and begin serving Healthy Indiana Plan members.  
      • In July 2010, we closed on the acquisition of certain assets of NovaSys Health, LLC, a leading third party administrator in Arkansas that will complement our existing Celtic business.  

      Michael F. Neidorff, Centene’s Chairman and Chief Executive Officer, stated, “Our team continues to focus on fundamentals and driving Centene to be a low-cost producer. These are key factors in producing another solid quarterly report and for the long-term success of our enterprise.”

      The following table depicts membership in Centene’s managed care organizations, by state, at June 30, 2010 and 2009:



      June 30,



      2010


      2009

      Arizona


      19,300


      16,200

      Florida


      113,100


      22,300

      Georgia


      295,600


      292,800

      Indiana


      212,700


      196,100

      Massachusetts


      30,100


      —

      Ohio


      159,300


      141,200

      South Carolina


      92,600


      46,000

      Texas


      475,500


      443,200

      Wisconsin


      133,600


      131,200

      Total at-risk membership


      1,531,800


      1,289,000

      Non-risk membership


      50,900


      114,000

      Total


      1,582,700


      1,403,000



      The following table depicts membership in Centene’s managed care organizations, by member category, at June 30, 2010 and 2009:



      June 30,



      2010


      2009

      Medicaid


      1,135,500


      958,600

      CHIP & Foster Care


      272,400


      261,400

      ABD & Medicare


      93,800


      69,000

      Other State programs


      30,100


      —

      Total at-risk membership


      1,531,800


      1,289,000

      Non-risk membership


      50,900


      114,000

      Total


      1,582,700


      1,403,000



      Statement of Operations

      • Premium and service revenues increased 12.8% for the three months ended June 30, 2010 over 2009 as a result of membership growth in each of our states.  This increase was moderated by the removal of pharmacy services in two states beginning in 2010.  These pharmacy carve outs had the effect of reducing 2010 second quarter revenue by approximately $48 million.
      • The consolidated HBR for the three months ended June 30, 2010 of 83.8% was an increase of 0.7% over the comparable period in 2009.  A reconciliation of the change in HBR from the prior year is presented below:


      Second Quarter 2009

      83.1%


      New markets reserved at higher rates

      0.6


      Net changes in existing markets

      0.1


      Second Quarter 2010

      83.8%








      • Consolidated G&A expense as a percent of premium and service revenues was 12.7% in the second quarter of 2010, a decrease from 13.9% in the second quarter of 2009.  The decrease reflects the leveraging of our expenses over higher revenues and the impact of our ongoing focus on system enhancements and operational efficiencies.  Additionally, we benefited by $0.03 per diluted share from a shift in start up costs for Mississippi from the second to the third quarter.
      • Effective July 1, 2010, our Georgia health plan will begin paying premium taxes and will no longer be subject to income taxes.  Accordingly, the deferred tax asset related to state net operating loss carry forwards was written off.  The write off increased income tax expense during the second quarter by $1.7 million, or $0.03 per diluted share.
      • Earnings per diluted share from continuing operations were $0.45, compared to $0.47 in the second quarter of 2009.  

      Balance Sheet and Cash Flow

      At June 30, 2010, we had cash and investments of $852.4 million, including $813.0 million held by our regulated entities and $39.4 million held by our unregulated entities.  Medical claims liabilities totaled $455.4 million, representing 48.2 days in claims payable, an increase of 0.5 days from March 31, 2010.  Total debt was $252.8 million and debt to capitalization was 24.5%.  

      Cash flow from operations through June 30, 2010 was $(98.3) million and was impacted by 1) $86.0 million decrease in unearned revenue due to advance payments received in December 2009 for January 2010 premium payments and 2) $57.7 million increase in premium and related receivables for June premium payments deferred by several states until July 2010.  During the second half of 2010, we expect cash flow from operations to return to historical levels, although the timing of premium payments from each state can vary from period to period.

      A reconciliation of the change in days in claims payable from the immediately preceding quarter-end is presented below:

      Days in claims payable, March 31, 2010

      47.7


        Timing of claims payments

      0.8


        Payment of annual provider bonuses

      (0.5)


        Impact of new business

      0.3


        Pharmacy payment timing

      (0.1)


      Days in claims payable, June 30, 2010

      48.2





      Outlook

      The table below depicts our guidance from continuing operations for 2010:



      Full Year 2010




      Low


      High 


      Premium and Service revenues (in millions)


      $    4,350


      $  4,450


      Earnings per diluted share (EPS)


      $    1.78


      $  1.86


      HBR %


      83.5%


      84.5%


      G&A %


      12.4%


      12.9%








      Diluted Shares Outstanding (in thousands)


      50,500










      Based upon known rate adjustments and preliminary discussions with our states that finalize rates in the second half of the year, we currently estimate our 2010 composite premium rate increase to be between 1% and 3%.

      Conference Call

      As previously announced, we will host a conference call Tuesday, July 27, 2010, at 8:30 A.M. (Eastern Time) to review the financial results for the second quarter ended June 30, 2010, and to discuss our business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call.  

      Investors and other interested parties are invited to listen to the conference call by dialing 800-860-2442 in the U.S. and Canada; +1-412-858-4600 from abroad; or via a live, audio webcast on our website at www.centene.com, under the Investors section.

      A replay will be available for on-demand listening shortly after the completion of the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, July 26, 2011, at the aforementioned URL, or by dialing 877-344-7529 in the U.S. and Canada, or +1-412-317-0088 from abroad and entering the playback conference number 442132.

      About Centene Corporation

      Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to other state-sponsored programs, and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management.

      The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company’s estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Actual results may differ from projections or estimates due to a variety of important factors, including Centene’s ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare.  The expiration, cancellation or suspension of Centene’s Medicaid Managed Care contracts by state governments would also negatively affect Centene.  

      Tables Follow



      CENTENE CORPORATION AND SUBSIDIARIES

      CONSOLIDATED BALANCE SHEETS
      (In thousands, except share data)
      (Unaudited)



      June 30,
      2010


      December 31,
      2009


      ASSETS







      Current assets:







         Cash and cash equivalents of continuing operations, including $5,154 and $8,667, respectively, from
          consolidated variable interest entities


      $

      264,723

      $

      400,951


         Cash and cash equivalents of discontinued operations



      877


      2,801


         Total cash and cash equivalents



      265,600


      403,752


         Premium and related receivables, net of allowance for uncollectible accounts of $1,336 and $1,338,
          respectively, including $7,266 and $11,313, respectively, from consolidated variable interest entities



      164,420


      103,456


         Short-term investments, at fair value (amortized cost $29,542 and $39,230, respectively)



      29,660


      39,554


         Other current assets, including $3,918 and $4,507, respectively, from consolidated variable interest entities



      83,843


      64,866


         Current assets of discontinued operations other than cash



      2,314


      4,506


             Total current assets



      545,837


      616,134


      Long-term investments, at fair value (amortized cost $522,589 and $514,256, respectively)



      537,399


      525,497


      Restricted deposits, at fair value (amortized cost $20,485 and $20,048, respectively)



      20,570


      20,132


      Property, software and equipment, net of accumulated depreciation of $118,995 and $103,883, respectively,
      including $138,998 and $89,219, respectively, from consolidated variable interest entities



      313,839


      230,421


      Goodwill



      244,304


      224,587


      Intangible assets, net



      24,589


      22,479


      Other long-term assets



      35,557


      36,829


      Long-term assets of discontinued operations



      11,442


      26,285


             Total assets


      $

      1,733,537

      $

      1,702,364


      LIABILITIES AND STOCKHOLDERS' EQUITY







      Current liabilities:







         Medical claims liability


      $

      455,375

      $

      470,932


         Accounts payable and accrued expenses, including $30,366 and $14,020, respectively, from consolidated
          variable interest entities



      167,613


      132,001


         Unearned revenue



      5,695


      91,644


         Current portion of long-term debt



      771


      646


         Current liabilities of discontinued operations



      7,365


      20,685


             Total current liabilities



      636,819


      715,908


      Long-term debt



      252,028


      307,085


      Other long-term liabilities



      64,870


      59,561


      Long-term liabilities of discontinued operations



      652


      383


             Total liabilities



      954,369


      1,082,937









      Commitments and contingencies














      Stockholders' equity:







         Common stock, $.001 par value; authorized 100,000,000 shares; 51,654,541 issued and 49,210,505
           outstanding at June 30, 2010, and 45,593,383 shares issued and 43,179,373 shares outstanding at
            December 31, 2009



      52


      46


         Additional paid-in capital



      395,926


      281,806


         Accumulated other comprehensive income:







          Unrealized gain on investments, net of tax



      9,400


      7,348


         Retained earnings



      405,682


      358,907


         Treasury stock, at cost (2,444,036 and 2,414,010 shares, respectively)



      (47,830)


      (47,262)


         Total Centene Corporation stockholders' equity



      763,230


      600,845


         Noncontrolling interest



      15,938


      18,582


             Total stockholders' equity



      779,168


      619,427


             Total liabilities and stockholders' equity


      $

      1,733,537

      $

      1,702,364





      CONSOLIDATED STATEMENTS OF OPERATIONS
      (In thousands, except share data)
      (Unaudited)


      Three Months Ended

      June 30,


      Six Months Ended

      June 30,



      2010



      2009


      2010



      2009


      Revenues:















         Premium

      $

      1,025,928



      $

      909,698


      $

      2,025,243



      $

      1,794,704


         Service


      24,682




      21,591



      47,589




      45,440


             Premium and service revenues


      1,050,610




      931,289



      2,072,832




      1,840,144


         Premium tax


      26,162




      108,180



      72,661




      131,760


             Total revenues


      1,076,772




      1,039,469



      2,145,493




      1,971,904


      Expenses:















         Medical costs


      859,335




      755,706



      1,699,043




      1,495,046


         Cost of services


      15,707




      14,559



      32,859




      30,521


         General and administrative expenses


      133,470




      129,221



      268,977




      251,500


         Premium tax


      26,551




      108,548



      73,294




      132,490


             Total operating expenses


      1,035,063




      1,008,034



      2,074,173




      1,909,557


             Earnings from operations


      41,709




      31,435



      71,320




      62,347


      Other income (expense):















         Investment and other income


      4,142




      4,418



      11,199




      8,031


         Interest expense


      (3,869)




      (4,160)



      (7,682)




      (8,146)


             Earnings from continuing operations, before income
              tax expense


      41,982




      31,693



      74,837




      62,232


         Income tax expense


      17,254




      11,789



      29,779




      22,634


             Earnings from continuing operations, net of income
              tax expense


      24,728




      19,904



      45,058




      39,598


      Discontinued operations, net of income tax (benefit)
      expense of $(90), $(196), $4,350 and $(356),
       respectively


      (226)




      (485)



      3,694




      (934)


             Net earnings


      24,502




      19,419



      48,752




      38,664


      Noncontrolling interest (loss)


      1,729




      (811)



      1,977




      (24)


             Net earnings attributable to Centene Corporation

      $

      22,773



      $

      20,230


      $

      46,775



      $

      38,688

















      Amounts attributable to Centene Corporation common
      stockholders:















         Earnings from continuing operations, net of income tax
         expense

      $

      22,999



      $

      20,715


      $

      43,081



      $

      39,622


         Discontinued operations, net of income tax (benefit)
          expense


      (226)




      (485)



      3,694




      (934)


         Net earnings

      $

      22,773



      $

      20,230


      $

      46,775



      $

      38,688

















      Net earnings (loss) per common share attributable to
      Centene Corporation:















         Basic:















          Continuing operations

      $

      0.46



      $

      0.48


      $

      0.89



      $

      0.92


          Discontinued operations


      —




      (0.01)



      0.08




      (0.02)


          Earnings per common share

      $

      0.46



      $

      0.47


      $

      0.97



      $

      0.90


         Diluted:















           Continuing operations

      $

      0.45



      $

      0.47


      $

      0.86



      $

      0.90


           Discontinued operations


      —




      (0.01)



      0.08




      (0.02)


           Earnings per common share

      $

      0.45



      $

      0.46


      $

      0.94



      $

      0.88

















      Weighted average number of shares outstanding:















           Basic


      49,135,552




      43,001,157



      48,203,312




      43,034,390


           Diluted


      50,866,318




      44,242,339



      49,807,084




      44,240,071





      CENTENE CORPORATION AND SUBSIDIARIES
      CONSOLIDATED STATEMENTS OF CASH FLOWS
      (In thousands)
      (Unaudited)


      Six Months Ended June 30,



      2010


      2009









      Cash flows from operating activities:







         Net earnings

      $

      48,752


      $

      38,664


         Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:







           Depreciation and amortization


      24,918



      20,892


           Stock compensation expense


      6,888



      7,611


           (Gain) loss on sale of investments, net


      (3,987)



      450


           (Gain) on sale of UHP


      (8,201)



      --


           Deferred income taxes


      4,928



      1,512


         Changes in assets and liabilities:







           Premium and related receivables


      (57,718)



      (23,327)


           Other current assets


      948



      1,357


           Other assets


      1,719



      (608)


           Medical claims liabilities


      (28,868)



      17,093


           Unearned revenue


      (85,950)



      44,129


           Accounts payable and accrued expenses


      (3,536)



      (49,377)


           Other operating activities


      1,851



      3,723


               Net cash (used in) provided by operating activities


      (98,256)



      62,119


      Cash flows from investing activities:







         Capital expenditures


      (63,602)



      (29,833)


         Purchases of investments


      (306,124)



      (415,052)


         Proceeds from asset sales


      13,420



      --


         Sales and maturities of investments


      291,735



      377,320


         Investments in acquisitions, net of cash acquired


      (21,473)



      (7,621)


               Net cash used in investing activities


      (86,044)



      (75,186)


      Cash flows from financing activities:







         Proceeds from exercise of stock options


      1,759



      1,109


         Proceeds from borrowings


      42,161



      288,000


         Proceeds from stock offering


      104,534



      --


         Payment of long-term debt


      (97,193)



      (264,135)


         Distributions to noncontrolling interest


      (4,840)



      (707)


         Excess tax benefits from stock compensation


      295



      15


         Common stock repurchases


      (568)



      (5,447)


         Debt issue costs


      --



      (368)


               Net cash provided by financing activities


      46,148



      18,467


               Net (decrease) increase in cash and cash equivalents


      (138,152)



      5,400


      Cash and cash equivalents, beginning of period


      403,752



      379,099


      Cash and cash equivalents, end of period

      $

      265,600


      $

      384,499









      Supplemental disclosures of cash flow information:







         Interest paid

      $

      7,320


      $

      7,658


         Income taxes paid

      $

      27,940


      $

      31,512









      Supplemental disclosure of non-cash investing and financing activities:







         Contribution from noncontrolling interest

      $

      306


      $

      5,107





      CENTENE CORPORATION
      CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA


      Q2


      Q1


      Q4


      Q3


      Q2


      2010


      2010


      2009


      2009


      2009

      MEMBERSHIP










      Managed Care:










         Arizona

      19,300


      19,000


      18,100


      17,400


      16,200

         Florida

      113,100


      105,900


      102,600


      84,400


      22,300

         Georgia

      295,600


      301,000


      309,700


      303,400


      292,800

         Indiana

      212,700


      211,400


      208,100


      200,700


      196,100

         Massachusetts

      30,100


      26,900


      27,800


      500


      —

         Ohio

      159,300


      156,000


      150,800


      151,200


      141,200

         South Carolina

      92,600


      53,900


      48,600


      46,100


      46,000

         Texas

      475,500


      459,600


      455,100


      450,200


      443,200

         Wisconsin

      133,600


      134,900


      134,800


      132,500


      131,200

             Total at-risk membership

      1,531,800


      1,468,600


      1,455,600


      1,386,400


      1,289,000

         Non-risk membership

      50,900


      62,200


      63,700


      63,200


      114,000

             TOTAL

      1,582,700


      1,530,800


      1,519,300


      1,449,600


      1,403,000











         Medicaid

      1,135,500


      1,088,300


      1,081,400


      1,040,000


      958,600

         CHIP & Foster Care

      272,400


      266,300


      263,600


      263,400


      261,400

         ABD & Medicare

      93,800


      87,100


      82,800


      82,500


      69,000

         Other State programs

      30,100


      26,900


      27,800


      500


      —

             Total at-risk membership

      1,531,800


      1,468,600


      1,455,600


      1,386,400


      1,289,000

         Non-risk membership

      50,900


      62,200


      63,700


      63,200


      114,000

             TOTAL

      1,582,700


      1,530,800


      1,519,300


      1,449,600


      1,403,000











      Specialty Services(a):










         Cenpatico Behavioral Health










           Arizona

      119,700


      119,300


      120,100


      117,300


      110,500

           Kansas

      39,100


      39,800


      41,400


      41,000


      41,100

      Bridgeway Health Solutions










         Long-term Care

      2,800


      2,700


      2,600


      2,500


      2,400

             TOTAL

      161,600


      161,800


      164,100


      160,800


      154,000











      (a) Includes external membership only.




















      REVENUE PER MEMBER PER MONTH(b)

      $

      208.58


      $

      215.95(c)


      $

      226.42


      $

      222.77


      $

      219.75











      CLAIMS(b)










         Period-end inventory

      480,400


      341,400


      423,400


      414,900


      362,200

         Average inventory

      306,900


      283,900


      279,000


      227,100


      234,500

         Period-end inventory per member

      0.31


      0.23


      0.29


      0.30


      0.28

      (b) Revenue per member and claims information are presented for the Managed Care at-risk members.

      (c) Reduction in revenue per member per month is a result of the pharmacy carve-outs in 2010.






      Q2


      Q1


      Q4


      Q3


      Q2


      2010


      2010


      2009


      2009


      2009











      DAYS IN CLAIMS PAYABLE










      Medical

      47.2


      46.6


      48.1


      47.1


      47.5

      Pharmacy

      1.0


      1.1


      2.0


      1.8


      1.5

      TOTAL

      48.2


      47.7


      50.1


      48.9


      49.0

      Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.











      CASH AND INVESTMENTS (in millions)









      Regulated

      $

      813.0


      $

      917.9


      $

      949.9


      $

      911.4


      $

      825.8

      Unregulated


      39.4



      51.3



      36.2



      27.6



      27.0

      TOTAL

      $

      852.4


      $

      969.2


      $

      986.1


      $

      939.0


      $

      852.8











      DEBT TO CAPITALIZATION

      24.5%


      23.7%


      33.2%


      31.9%


      33.0%

      Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).  




      Operating Ratios:


      Three Months Ended

      June 30,


      Six Months Ended

      June 30,


      2010



      2009


      2010



      2009

      Health Benefits Ratios:














       Medicaid and CHIP

      83.4

      %



      83.7

      %


      84.5

      %



      84.2

      %

       ABD and Medicare

      86.5




      82.6



      83.4




      82.0


       Specialty Services

      81.7




      79.8



      81.2




      79.0


       Total

      83.8




      83.1



      83.9




      83.3
















      Total General & Administrative Expense
      Ratio

      12.7

      %



      13.9

      %


      13.0

      %



      13.7

      %




      MEDICAL CLAIMS LIABILITY (In thousands)
      The changes in medical claims liability are
      summarized as follows:

      Balance, June 30, 2009

      $

      406,834


      Incurred related to:




      Current period


      3,427,022


      Prior period


      (59,502)


      Total incurred


      3,367,520


      Paid related to:




      Current period


      2,980,741


      Prior period


      338,238


      Total paid


      3,318,979


      Balance, June 30, 2010

      $

      455,375





      Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability. Any reduction in the "Incurred related to: Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period." As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

      The amount of the "Incurred related to: Prior period" above includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, increased receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to June 30, 2009.

      SOURCE Centene Corporation

      Modal title

      Also from this source

      Ambetter Health Announces 2027 Marketplace Offerings, Including Enhanced Condition-Specific Coverage Options

      Ambetter Health Announces 2027 Marketplace Offerings, Including Enhanced Condition-Specific Coverage Options

      Ambetter Health, the Health Insurance Marketplace product of Centene Corporation (NYSE: CNC), today announced its 2027 Marketplace offerings,...

      Ambetter Health Announces 2027 Marketplace Offerings, Including Enhanced Condition-Specific Coverage Options

      Ambetter Health Announces 2027 Marketplace Offerings, Including Enhanced Condition-Specific Coverage Options

      Ambetter Health, the Health Insurance Marketplace product of Centene Corporation (NYSE: CNC), today announced its 2027 Marketplace offerings,...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Earnings

      Earnings

      Earnings Forecasts & Projections

      Earnings Forecasts & Projections

      Conference Call Announcements

      Conference Call Announcements

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.